Advancements in Targeted Therapies for Advanced Breast Cancer

This chapter explores recent clinical trials on advanced breast cancer treatments, specifically Vepdegastrant and camizestrant. It underscores the need for targeted therapies for specific ESR1 mutations and the significance of insights from practicing clinicians in shaping cancer research.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app